Phytofabrication of silver and zinc oxide nanoparticles using the fruit extract of Phyllanthus emblica and its potential anti-diabetic and anti-cancer activity.

FRUIT extracts; ZINC oxide; SILVER oxide; ANTINEOPLASTIC agents; METAL nanoparticles; PHYLLANTHUS

Phytochemicals capacity to reduce metal into nanoparticles has sparked a new eco-friendly method to build green nanotechnology. Synthesis of nanoparticles using a biological approach with valuable medicinal applications is an essential feature of modern nanotechnology. The present study attempts to synthesize silver (PE-AgNPs) and zinc oxide (PE-ZnONPs) nanoparticles using Phyllanthus emblica fruit ethanolic extract and evaluates their therapeutic potential. In our present study, the secondary metabolites of the extract were determined by Gas Chromatography-Mass Spectra (GC-MS.) Nanoparticles were characterized using analytical tools. The PE-AgNPs and PE-ZnONPs nanoparticles have shown potential inhibition activity against α-amylase (IC50 170.60 ± 0.94 and 160.82 ± 0.88 µg/mL), α-glucosidase (IC50 80.24 ± 1.38 and 70.02 ± 0.59 µg/mL) and increased glucose uptake (180.42 ± 0.78 and 110.52 ± 0.84 µg/mL). In-vitro MTT assay of PE-AgNPs and PE-ZnONPs nanoparticles revealed the effective anticancer potential against the A549 cancer cell line with an IC50 value of 27.52 ± 1.12 and 70.64 ± 1.4 µg/mL. The synthesized bioactive compounds can be the alternative eco-friendly potential for an antidiabetic and anticancer substitute which can be further recommended for pharmacological applications. [ABSTRACT FROM AUTHOR]

Copyright of Particulate Science & Technology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)